Shanghai Sinobioway Sunterra Biotech

Shanghai Sinobioway Sunterra Biotech is a biotechnology company based in Shanghai, China, specializing in the development of innovative vaccines and recombinant protein therapies. As a subsidiary of the Sinobioway Group, the company focuses on addressing infectious diseases, with a primary emphasis on its COVID-19 vaccine program. The company's lead candidate is a recombinant protein vaccine that has undergone clinical evaluation to provide protection against SARS-CoV-2. By utilizing advanced protein expression technologies, the firm aims to create a robust pipeline of biologics. Shanghai Sinobioway Sunterra Biotech benefits from the strategic resources and academic ties of the Peking University Sinobioway Group. The company represents a key component of the group's efforts to modernize vaccine production in China.